Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Gains from Sales and Divestitures (2016 - 2025)

Neuronetics (STIM) has disclosed Gains from Sales and Divestitures for 10 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 4.62% to $1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.3 million, a 4.62% decrease, with the full-year FY2024 number at $1.5 million, down 19.69% from a year prior.
  • Gains from Sales and Divestitures was $1.3 million for Q3 2025 at Neuronetics, up from $1.3 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.8 million in Q4 2023 to a low of $250000.0 in Q1 2021.
  • A 5-year average of $990789.5 and a median of $967000.0 in 2025 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 751.72% in 2021, then decreased 26.23% in 2024.
  • Neuronetics' Gains from Sales and Divestitures stood at $780000.0 in 2021, then dropped by 9.62% to $705000.0 in 2022, then soared by 158.58% to $1.8 million in 2023, then dropped by 19.69% to $1.5 million in 2024, then dropped by 8.4% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Gains from Sales and Divestitures are $1.3 million (Q3 2025), $1.3 million (Q2 2025), and $967000.0 (Q1 2025).